Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

CTXRCitius Pharmaceuticals, Inc.

Nasdaq · CIK 0001506251
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end0930
XBRL facts436

Identity from submissions API

NameCitius Pharmaceuticals, Inc.
CIK0001506251
TickersCTXR
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN273425913
LEI—
Fiscal year end0930
State of incorporationNV NV
Phone(908) 967-6676
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)1

Former names

  • Trail One, Inc. (2010-12-20T05:00:00.000Z → 2014-09-18T04:00:00.000Z)
  • TrailOne, Inc. (2010-11-23T05:00:00.000Z → 2011-01-21T05:00:00.000Z)
Business address
11 COMMERCE DRIVE
1ST FLOOR
CRANFORD
NJ
07016
NJ
Mailing address
11 COMMERCE DRIVE
1ST FLOOR
CRANFORD
NJ
07016
NJ

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

638 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-04 8-K CURRENT REPORT 8.01,9.01 0001213900-26-115962 001-38174 261522871 34 225183 1 1
2026-10-26 8-K CURRENT REPORT 2.02,9.01 0001213900-26-112478 001-38174 261485957 34 232058 1 1
2026-08-21 8-K CURRENT REPORT 3.01 0001213900-26-092604 001-38174 261304897 34 188528 1 1
2026-08-14 10-Q QUARTERLY REPORT 0001213900-26-090185 001-38174 261282799 34 6754240 1 1
2026-08-14 8-K CURRENT REPORT 2.02,9.01 0001213900-26-090181 001-38174 261282781 34 356930 1 1
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001649553-26-000102 005-90253 261280087 34 12480
2026-08-10 UPLOAD filename1.pdf 0000000000-26-007819 333-296195 181413
2026-08-05 8-K CURRENT REPORT 8.01,9.01 0001213900-26-085432 001-38174 261241614 34 255849 1 1
2026-06-04 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001213900-26-065310 9587
2026-06-02 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001857 333-296195 261058757 33 1945
2026-06-01 8-K CURRENT REPORT 8.01,9.01 0001213900-26-063531 001-38174 261051425 34 268785 1 1
2026-05-29 CORRESP filename1.htm 0001213900-26-062830 7644
2026-05-22 S-3 REGISTRATION STATEMENT 0001213900-26-060644 333-296195 261014871 33 416673 1 1
2026-05-15 8-K CURRENT REPORT 2.02,9.01 0001213900-26-057876 001-38174 26988960 34 332389 1 1
2026-05-15 10-Q QUARTERLY REPORT 0001213900-26-057842 001-38174 26988531 34 6089789 1 1
2026-05-08 8-K CURRENT REPORT 1.01,9.01 0001213900-26-053916 001-38174 26958862 34 231814 1 1
2026-04-29 8-K CURRENT REPORT 3.02,8.01,9.01 0001213900-26-049338 001-38174 26916757 34 255082 1 1
2026-04-24 8-K CURRENT REPORT 1.01,8.01,9.01 0001213900-26-047599 001-38174 26895468 34 938210 1 1
2026-04-24 424B5 PROSPECTUS SUPPLEMENT 0001213900-26-047296 333-277319 26890769 33 407944
2026-04-06 8-K CURRENT REPORT 5.07 0001213900-26-040474 001-38174 26841392 34 200205 1 1
2026-03-31 8-K CURRENT REPORT 8.01,9.01 0001213900-26-037524 001-38174 26822586 34 246005 1 1
2026-03-10 8-K CURRENT REPORT 8.01,9.01 0001213900-26-025459 001-38174 26737427 34 267753 1 1
2026-03-04 8-K CURRENT REPORT 8.01,9.01 0001213900-26-023439 001-38174 26719096 34 320550 1 1
2026-02-24 ARS FORM ARS 0001213900-26-019569 001-38174 26667601 34 1339148
2026-02-24 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-26-019568 001-38174 26667600 34 1528848
2026-02-24 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-26-019566 001-38174 26667596 34 3350127 1 1
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001649553-26-000024 005-90253 26639896 34 12243
2026-02-13 8-K CURRENT REPORT 2.02,3.01,9.01 0001213900-26-015895 001-38174 26629045 34 319218 1 1
2026-02-13 10-Q QUARTERLY REPORT 0001213900-26-015878 001-38174 26628960 34 5225909 1 1
2026-01-28 10-K/A AMENDMENT NO. 1 TO FORM 10-K 0001213900-26-008861 001-38174 26572922 34 567976 1 1
2025-12-23 8-K CURRENT REPORT 2.02,9.01 0001213900-25-125413 001-38174 251601363 34 306214 1 1
2025-12-23 10-K ANNUAL REPORT 0001213900-25-125333 001-38174 251600869 34 7336284 1 1
2025-12-17 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001213900-25-122793 8035
2025-12-01 8-K CURRENT REPORT 7.01,8.01,9.01 0001213900-25-116760 001-38174 251540509 34 21961295 1 1
2025-10-27 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001649553-25-000174 005-90253 251418040 34 16073
2025-10-23 8-K CURRENT REPORT 7.01,9.01 0001213900-25-101741 001-38174 251413796 34 51623041 1 1
2025-10-21 8-K CURRENT REPORT 1.01,8.01,9.01 0001213900-25-100847 001-38174 251407547 34 939369 1 1
2025-10-21 424B5 PROSPECTUS SUPPLEMENT 0001213900-25-100559 333-277319 251405521 33 390442
2025-09-23 4 xslF345X05/ownership.xml 0001213900-25-090602 25793
2025-09-12 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001213900-25-087227 8044
2025-08-12 4 xslF345X05/ownership.xml 0001213900-25-075035 31330
2025-08-12 8-K CURRENT REPORT 2.02,9.01 0001213900-25-075034 001-38174 251207572 34 293959 1 1
2025-08-12 10-Q QUARTERLY REPORT 0001213900-25-074997 001-38174 251207262 34 4729803 1 1
2025-07-25 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001213900-25-067797 6749
2025-07-08 8-K CURRENT REPORT 8.01,9.01 0001213900-25-062099 001-38174 251111567 34 200901 1 1
2025-06-12 8-K CURRENT REPORT 1.01,8.01,9.01 0001213900-25-053607 001-38174 251041756 34 896549 1 1
2025-06-11 424B5 PROSPECTUS SUPPLEMENT 0001213900-25-053274 333-277319 251038807 33 390513
2025-06-09 8-K CURRENT REPORT 3.03,5.03,5.07,9.01 0001213900-25-052718 001-38174 251035182 34 3244728 1 1
2025-06-03 8-K CURRENT REPORT 1.01,2.03,9.01 0001213900-25-050822 001-38174 251020057 34 260750 1 1
2025-05-30 8-K CURRENT REPORT 3.01 0001213900-25-049550 001-38174 251012212 34 192712 1 1
2025-05-14 10-Q QUARTERLY REPORT 0001213900-25-043360 001-38174 25946292 34 4340413 1 1
2025-05-14 8-K CURRENT REPORT 2.02,9.01 0001213900-25-043362 001-38174 25946273 34 312506 1 1
2025-04-28 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-25-035757 001-38174 25875954 34 1531398
2025-04-28 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-25-035755 001-38174 25875948 34 1303389
2025-04-18 PRE 14A PRELIMINARY PROXY STATEMENT 0001213900-25-033368 001-38174 25850492 34 1308023
2025-04-18 8-K CURRENT REPORT 1.01,3.02,3.03,5.03,9.01 0001213900-25-033366 001-38174 25850486 34 278360 1 1
2025-04-03 8-K CURRENT REPORT 1.01,9.01 0001213900-25-028622 001-38174 25809632 34 203717 1 1
2025-04-02 8-K CURENT REPORT 1.01,8.01,9.01 0001213900-25-028003 001-38174 25804338 34 732694 1 1
2025-04-02 424B5 PROSPECTUS SUPPLEMENT 0001213900-25-027540 333-277319 25802170 33 375341
2025-03-10 8-K CURRENT REPORT 5.07 0001213900-25-022237 001-38174 25724166 34 206690 1 1
2025-02-14 8-K CURRENT REPORT 8.01,9.01 0001213900-25-014359 001-38174 25630226 34 298320 1 1
2025-02-14 10-Q QUARTERLY REPORT 0001213900-25-014321 001-38174 25629669 34 3793242 1 1
2025-02-06 8-K CURRENT REPORT 8.01,9.01 0001213900-25-010747 001-38174 25595688 34 258673 1 1
2025-01-27 10-K/A AMENDMENT NO. 1 TO FORM 10-K 0001213900-25-006997 001-38174 25559175 34 443335 1 1
2025-01-27 ARS FORM ARS 0001213900-25-006993 001-38174 25559126 34 965166
2025-01-27 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-25-006987 001-38174 25559080 34 1372186
2025-01-27 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-25-006984 001-38174 25559031 34 2642529 1 1
2025-01-16 PRE 14A PRELIMINARY PROXY STATEMENT 0001213900-25-004221 001-38174 25535996 34 4155633 1 1
2025-01-08 8-K CURRENT REPORT 1.01,8.01,9.01 0001213900-25-002071 001-38174 25518561 34 640720 1 1
2025-01-08 424B5 PROSPECTUS SUPPLEMENT 0001213900-25-001826 333-277319 25516711 33 385971
2025-01-07 8-K CURRENT REPORT 8.01,9.01 0001213900-25-001408 001-38174 25513585 34 292270 1 1
2024-12-27 8-K CURRENT REPORT 2.02,9.01 0001213900-24-113158 001-38174 241586279 34 320930 1 1
2024-12-27 10-K ANNUAL REPORT 0001213900-24-113149 001-38174 241586207 34 6073292 1 1
2024-12-20 8-K FORM 8-K 8.01 0001213900-24-111212 001-38174 241568362 34 194426 1 1
2024-11-27 SC 13D/A AMENDMENT NO. 2 TO SCHEDULE 13D 0001213900-24-103453 005-90253 241511011 34 35335
2024-11-26 8-K CURRENT REPORT 3.03,5.03,8.01,9.01 0001213900-24-102833 001-38174 241503955 34 1414838 1 1
2024-11-25 8-K CURRENT REPORT 8.01,9.01 0001213900-24-102265 001-38174 241497074 34 232858 1 1
2024-11-18 8-K CURRENT REPORT 1.01,8.01,9.01 0001213900-24-099649 001-38174 241471672 34 654391 1 1
2024-11-18 424B5 PROSPECTUS SUPPLEMENT 0001213900-24-099369 333-277319 241469828 33 385596
2024-11-13 8-K CURRENT REPORT 3.01 0001213900-24-097495 001-38174 241454821 34 202005 1 1
2024-11-12 4 xslF345X05/ownership.xml 0001213900-24-096895 19985
2024-11-12 4 xslF345X05/ownership.xml 0001213900-24-096894 7043
2024-11-12 4 xslF345X05/ownership.xml 0001213900-24-096893 18234
2024-11-12 4 xslF345X05/ownership.xml 0001213900-24-096892 20890
2024-11-12 4 xslF345X05/ownership.xml 0001213900-24-096891 11443
2024-11-12 4 xslF345X05/ownership.xml 0001213900-24-096890 19389
2024-11-12 4 xslF345X05/ownership.xml 0001213900-24-096889 8294
2024-11-12 4 xslF345X05/ownership.xml 0001213900-24-096888 27342
2024-11-12 4 xslF345X05/ownership.xml 0001213900-24-096887 20001
2024-11-12 8-K CURRENT REPORT 8.01,9.01 0001213900-24-096268 001-38174 241443738 34 269620 1 1
2024-09-27 4 xslF345X05/ownership.xml 0001213900-24-082813 30298
2024-09-27 4 xslF345X05/ownership.xml 0001213900-24-082812 25843
2024-09-27 8-K FORM 8-K 1.01 0001213900-24-082809 001-38174 241336056 34 200233 1 1
2024-09-13 8-K CURRENT REPORT 1.01 0001213900-24-078288 001-38174 241296506 34 198100 1 1
2024-09-11 8-K FORM 8-K 3.01 0001213900-24-077777 001-38174 241293334 34 200994 1 1
2024-09-05 8-K CURRENT REPORT 8.01,9.01 0001213900-24-076108 001-38174 241281580 34 265285 1 1
2024-08-30 4 OWNERSHIP DOCUMENT 0001213900-24-074506 23163
2024-08-30 4 OWNERSHIP DOCUMENT 0001213900-24-074505 23153
2024-08-16 8-K CURRENT REPORT 1.01,2.03,8.01,9.01 0001213900-24-070285 001-38174 241217188 34 640687 1 1
2024-08-16 SC 13D SCHEDULE 13D 0001213900-24-070284 814627
2024-08-14 4 xslF345X05/ownership.xml 0001213900-24-069245 001-41534 241210027 34 10951
2024-08-14 3 xslF345X02/ownership.xml 0001213900-24-069234 001-41534 241209993 34 11431
2024-08-12 8-K CURRENT REPORT 2.02,9.01 0001213900-24-067778 001-38174 241198032 34 313686 1 1
2024-08-12 424B5 PROSPECTUS SUPPLEMENT 0001213900-24-067764 333-277319 241197879 33 390229
2024-08-12 10-Q QUARTERLY REPORT 0001213900-24-067732 001-38174 241197644 34 4285944 1 1
2024-08-08 8-K CURRENT REPORT 8.01,9.01 0001213900-24-066357 001-38174 241186352 34 311140 1 1
2024-05-21 8-K CURRENT REPORT 8.01,9.01 0001213900-24-045573 001-38174 24969323 34 249808 1 1
2024-05-14 8-K CURRENT REPORT 2.02,9.01 0001213900-24-042966 001-38174 24944803 34 331718 1 1
2024-05-14 10-Q QUARTERLY REPORT 0001213900-24-042920 001-38174 24944231 34 3584001 1 1
2024-05-08 SC 13G/A us17322u2078_050724.txt 0001086364-24-007620 005-90253 24925339 34 12628
2024-04-30 8-K CURRENT REPORT 1.01,8.01,9.01 0001213900-24-037861 001-38174 24897618 34 651009 1 1
2024-04-26 424B5 PROSPECTUS SUPPLEMENT 0001213900-24-036696 333-277319 24884877 33 388351
2024-04-05 8-K CURRENT REPORT 8.01 0001213900-24-030829 001-38174 24826590 34 202723 1 1
2024-04-05 4 xslF345X05/ownership.xml 0001213900-24-030811 24154
2024-04-05 4 xslF345X05/ownership.xml 0001213900-24-030812 27079
2024-03-18 4 xslF345X05/ownership.xml 0001213900-24-023487 5823
2024-03-18 8-K FORM 8-K 8.01,9.01 0001213900-24-023483 001-38174 24758982 34 226203 1 1
2024-03-18 3 xslF345X02/ownership.xml 0001213900-24-023481 9037
2024-03-13 8-K CURRENT REPORT 3.01,5.07 0001213900-24-022184 001-38174 24746352 34 215554 1 1
2024-03-01 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-03-01 16:01:00 9999999995-24-000586 333-277319 24712718 33 1951
2024-02-29 CORRESP filename1.htm 0001213900-24-018483 7396
2024-02-29 UPLOAD filename1.pdf 0000000000-24-002273 333-277319 40509
2024-02-23 S-3 REGISTRATION STATEMENT 0001213900-24-016515 333-277319 24671573 33 834639
2024-02-23 S-8 REGISTRATION STATEMENT 0001213900-24-016513 333-277315 24671484 33 284619
2024-02-15 8-K CURRENT REPORT 2.02,9.01 0001213900-24-014332 001-38174 24642301 34 307082 1 1
2024-02-14 10-Q QUARTERLY REPORT 0001213900-24-014096 001-38174 24639493 34 3109238 1 1
2024-02-14 8-K FORM 8-K 8.01,9.01 0001213900-24-013676 001-38174 24633010 34 224021 1 1
2024-01-31 SC 13G us17322u2078_013124.txt 0001086364-24-006038 005-90253 24582148 34 13512
2024-01-26 ARS FORM ARS 0001213900-24-006987 001-38174 24567948 34 1069147
2024-01-26 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-24-006978 001-38174 24567806 34 946322
2024-01-26 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-24-006971 001-38174 24567757 34 1590757
2024-01-23 8-K CURRENT REPORT 8.01,9.01 0001213900-24-005727 001-38174 24552517 34 242825 1 1
2024-01-05 8-K CURRENT REPORT 5.08 0001213900-24-001508 001-38174 24516220 34 201859 1 1
2024-01-02 8-K CURRENT REPORT 2.02,8.01,9.01 0001213900-24-000247 001-38174 24502366 34 330690 1 1
2023-12-29 10-K ANNUAL REPORT 0001213900-23-099889 001-38174 231527682 34 5675538 1 1
2023-10-24 425 CURRENT REPORT 0001013762-23-006008 001-38174 231341194 34 9250375
2023-10-24 8-K CURRENT REPORT 1.01,7.01,9.01 0001013762-23-006005 001-38174 231341191 34 9671842 1 1
2023-10-12 4 xslF345X05/ownership.xml 0001013762-23-003535 20417
2023-10-12 4 xslF345X05/ownership.xml 0001013762-23-003534 10104
2023-10-12 4 xslF345X05/ownership.xml 0001013762-23-003533 24649
2023-10-12 4 xslF345X05/ownership.xml 0001013762-23-003532 20432
2023-10-12 4 xslF345X05/ownership.xml 0001013762-23-003529 7194
2023-10-12 4 xslF345X05/ownership.xml 0001013762-23-003531 19099
2023-10-12 4 xslF345X05/ownership.xml 0001013762-23-003530 17882
2023-10-12 4 xslF345X05/ownership.xml 0001013762-23-003528 21669
2023-09-25 8-K CURRENT REPORT 8.01 0001213900-23-079162 001-38174 231276139 34 193331 1 1
2023-09-15 8-K CURRENT REPORT 3.01 0001213900-23-077043 001-38174 231259134 34 200731 1 1
2023-09-11 8-K CURRENT REPORT 7.01,9.01 0001213900-23-075610 001-38174 231246997 34 7402024 1 1
2023-09-08 8-K CURRENT REPORT 8.01,9.01 0001213900-23-075179 001-38174 231243737 34 222606 1 1
2023-08-15 8-K CURRENT REPORT 2.02,9.01 0001213900-23-067474 001-38174 231173437 34 312662 1 1
2023-08-14 10-Q QUARTERLY REPORT 0001213900-23-067024 001-38174 231169956 34 3439229 1 1
2023-08-10 8-K CURRENT REPORT 8.01,9.01 0001213900-23-065621 001-38174 231159587 34 244220 1 1
2023-07-31 8-K CURRENT REPORT 8.01,9.01 0001213900-23-061292 001-38174 231127577 34 222016 1 1
2023-06-29 8-K CURRENT REPORT 7.01,9.01 0001213900-23-052931 001-38174 231057566 34 8689801 1 1
2023-06-20 8-K CURRENT REPORT 8.01,9.01 0001213900-23-050034 001-38174 231025040 34 255143 1 1
2023-05-12 8-K CURRENT REPORT 2.02,9.01 0001213900-23-039083 001-38174 23916602 34 326356 1 1
2023-05-12 10-Q QUARTERLY REPORT 0001213900-23-039031 001-38174 23915916 34 3444944 1 1
2023-05-08 8-K CURRENT REPORT 1.01,8.01,9.01 0001213900-23-037345 001-38174 23897945 34 768694 1 1
2023-05-05 424B5 PROSPECTUS SUPPLEMENT 0001213900-23-036895 333-255005 23894031 33 322258
2023-04-24 8-K CURRENT REPORT 8.01,9.01 0001213900-23-032026 001-38174 23840266 34 226224 1 1
2023-04-03 8-K CURRENT REPORT 8.01,9.01 0001213900-23-026265 001-38174 23792604 34 225994 1 1
2023-02-10 S-8 REGISTRATION STATEMENT 0001213900-23-010331 333-269703 23612799 33 213501
2023-02-10 8-K CURRENT REPORT 2.02,9.01 0001213900-23-010323 001-38174 23612684 34 310877 1 1
2023-02-10 10-Q QUARTERLY REPORT 0001213900-23-010315 001-38174 23612530 34 2867925 1 1
2023-02-09 4 xslF345X03/ownership.xml 0001213900-23-009756 5636
2023-02-09 3 xslF345X02/ownership.xml 0001213900-23-009751 8926
2023-02-07 8-K CURRENT REPORT 5.07 0001213900-23-008959 001-38174 23595054 34 209083 1 1
2022-12-22 8-K CURRENT REPORT 2.02,9.01 0001213900-22-082228 001-38174 221482433 34 331441 1 1
2022-12-22 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-22-082226 001-38174 221482391 34 435079
2022-12-22 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-22-082224 001-38174 221482371 34 1262791
2022-12-22 10-K ANNUAL REPORT 0001213900-22-082217 001-38174 221482317 34 4586451 1 1
2022-12-01 8-K CURRENT REPORT 8.01,9.01 0001213900-22-076878 001-38174 221438986 34 237878 1 1
2022-11-21 8-K CURRENT REPORT 8.01,9.01 0001213900-22-074041 001-38174 221403723 34 227739 1 1
2022-11-15 4/A xslF345X03/ownership.xml 0001213900-22-072784 4827
2022-10-06 4 xslF345X03/ownership.xml 0001213900-22-062485 19322
2022-10-06 4 xslF345X03/ownership.xml 0001213900-22-062484 18177
2022-10-06 4 xslF345X03/ownership.xml 0001213900-22-062483 24577
2022-10-06 4 xslF345X03/ownership.xml 0001213900-22-062481 26365
2022-10-06 4 xslF345X03/ownership.xml 0001213900-22-062480 17405
2022-10-06 4 xslF345X03/ownership.xml 0001213900-22-062478 19322
2022-10-06 4 xslF345X03/ownership.xml 0001213900-22-062476 19333
2022-10-06 4 xslF345X03/ownership.xml 0001213900-22-062475 19318
2022-10-06 4 xslF345X03/ownership.xml 0001213900-22-062472 8821
2022-09-28 8-K CURRENT REPORT 8.01,9.01 0001213900-22-059746 001-38174 221276052 34 228406 1 1
2022-09-22 8-K CURRENT REPORT 8.01,9.01 0001213900-22-058035 001-38174 221259713 34 275567 1 1
2022-08-11 8-K CURRENT REPORT 2.02,9.01 0001213900-22-046925 001-38174 221156550 34 376262 1 1
2022-08-11 10-Q QUARTERLY REPORT 0001213900-22-046897 001-38174 221156271 34 3560421 1 1
2022-08-08 25-NSE xslF25X02/primary_doc.xml 0001354457-22-000444 001-38174 221145153 34 3126
2022-07-12 8-K CURRENT REPORT 8.01,9.01 0001213900-22-038873 001-38174 221079314 34 267773 1 1
2022-07-08 SC 13G us17322u2078_070822.txt 0000834237-22-010231 005-90253 221074999 34 12338
2022-05-25 8-K CURRENT REPORT 8.01,9.01 0001213900-22-029411 001-38174 22959355 34 281179 1 1
2022-05-12 8-K CURRENT REPORT 2.02,9.01 0001213900-22-025988 001-38174 22918589 34 352014 1 1
2022-05-12 10-Q QUARTERLY REPORT 0001213900-22-025975 001-38174 22918355 34 3537171 1 1
2022-05-06 8-K CURRENT REPORT FILING 8.01,9.01 0001213900-22-024524 001-38174 22901027 34 265552 1 1
2022-04-26 8-K CURRENT REPORT FILING 8.01,9.01 0001213900-22-021542 001-38174 22851999 34 263417 1 1
2022-04-13 8-K CURRENT REPORT FILING 5.02,9.01 0001213900-22-019528 001-38174 22823848 34 274392 1 1
2022-04-06 8-K CURRENT REPORT 8.01,9.01 0001213900-22-018307 001-38174 22809425 34 289990 1 1
2022-02-18 SC 13D/A AMENDMENT NO. 1 TO SCHEDULE 13D 0001213900-22-008488 005-90253 22653282 34 41975
2022-02-18 SC 13D/A AMENDMENT NO. 1 TO SCHEDULE 13D 0001213900-22-008485 005-90253 22653235 34 42259
2022-02-15 8-K CURRENT REPORT 8.01,9.01 0001213900-22-007787 001-38174 22637229 34 271543 1 1
2022-02-15 SC 13G/A SC 13G/A 0001193125-22-042443 005-90253 22636050 34 68234
2022-02-10 8-K CURRENT REPORT 2.02,9.01 0001213900-22-006452 001-38174 22614562 34 353874 1 1
2022-02-10 10-Q QUARTERLY REPORT 0001213900-22-006429 001-38174 22614101 34 2998337 1 1
2022-02-08 8-K CURRENT REPORT 5.07 0001213900-22-005921 001-38174 22602024 34 263986 1 1
2022-02-04 SC 13G us17322u2078_020422.txt 0000834237-22-007264 005-90253 22593494 34 13317
2021-12-20 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-21-066335 001-38174 211505455 34 455471
2021-12-20 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-21-066329 001-38174 211505410 34 772252
2021-12-15 10-K ANNUAL REPORT 0001213900-21-065464 001-38174 211494551 34 5999176 1 1
2021-12-15 8-K CURRENT REPORT 2.02,9.01 0001213900-21-065465 001-38174 211494533 34 366296 1 1
2021-12-06 8-K CURRENT REPORT 8.01,9.01 0001213900-21-063614 001-38174 211473203 34 273206 1 1
2021-10-13 4 xslF345X03/ownership.xml 0001213900-21-052678 23922
2021-10-13 4 xslF345X03/ownership.xml 0001213900-21-052677 24802
2021-10-13 4 xslF345X03/ownership.xml 0001213900-21-052674 17802
2021-10-13 4 xslF345X03/ownership.xml 0001213900-21-052676 15831
2021-10-13 4 xslF345X03/ownership.xml 0001213900-21-052672 17781
2021-10-13 4 xslF345X03/ownership.xml 0001213900-21-052673 17812
2021-10-13 4 xslF345X03/ownership.xml 0001213900-21-052675 16636
2021-10-13 4 xslF345X03/ownership.xml 0001213900-21-052671 7282
2021-10-13 4 xslF345X03/ownership.xml 0001213900-21-052670 17786
2021-09-07 8-K CURRENT REPORT 1.01,9.01 0001213900-21-046872 001-38174 211239350 34 298077 1 1
2021-08-12 8-K CURRENT REPORT 2.02,9.01 0001213900-21-042073 001-38174 211168251 34 387344 1 1
2021-08-12 10-Q QUARTERLY REPORT 0001213900-21-042071 001-38174 211168236 34 3659894 1 1
2021-07-26 4 xslF345X03/ownership.xml 0001213900-21-038698 16258
2021-07-26 4 xslF345X03/ownership.xml 0001213900-21-038697 15111
2021-07-26 4 xslF345X03/ownership.xml 0001213900-21-038696 20931
2021-07-26 4 xslF345X03/ownership.xml 0001213900-21-038695 23238
2021-07-26 4 xslF345X03/ownership.xml 0001213900-21-038694 14256
2021-07-26 4 xslF345X03/ownership.xml 0001213900-21-038693 16253
2021-07-26 4 xslF345X03/ownership.xml 0001213900-21-038692 16284
2021-07-26 4 xslF345X03/ownership.xml 0001213900-21-038690 16274
2021-07-23 424B4 PROSPECTUS 0001213900-21-038381 333-217956 211111235 33 200976
2021-07-08 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001213900-21-035564,2021-07-08 9999999995-21-002676 333-217956 211081579 33 1916
2021-07-07 8-K CURRENT REPORT 7.01,8.01,9.01 0001213900-21-035885 001-38174 211076350 34 6281960
2021-07-02 POS AM POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-1 0001213900-21-035564 333-217956 211070240 33 319811
2021-07-01 8-K CURRENT REPORT 8.01,9.01 0001213900-21-035203 001-38174 211064311 34 39629
2021-06-22 S-8 REGISTRATION STATEMENT 0001213900-21-033569 333-257282 211035826 33 167049
2021-06-22 8-K/A CURRENT REPORT 3.03,5.03,5.07,9.01 0001213900-21-033563 001-38174 211035717 34 41971
2021-06-08 8-K CURRENT REPORT 8.01,9.01 0001213900-21-031359 001-38174 211001361 34 38096
2021-06-07 8-K CURRENT REPORT 8.01,9.01 0001213900-21-031157 001-38174 21998429 34 66958
2021-05-28 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-21-029958 001-38174 21980848 34 30822
2021-05-24 8-K CURRENT REPORT 5.07 0001213900-21-028615 001-38174 21951545 34 26077
2021-05-20 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-05-20 16:00:00 9999999995-21-002046 333-256063 21946499 33 1902
2021-05-20 424B3 PROSPECTUS 0001213900-21-028165 333-256063 21944650 33 236591
2021-05-19 CORRESP filename1.htm 0001213900-21-027750 9327
2021-05-18 UPLOAD filename1.pdf 0000000000-21-006298 40414
2021-05-13 S-3 REGISTRATION STATEMENT 0001213900-21-025927 333-256063 21917349 33 342523
2021-05-13 10-Q QUARTERLY REPORT 0001213900-21-025920 001-38174 21917313 34 2725950 1
2021-05-13 8-K CURRENT REPORT 2.02,9.01 0001213900-21-025916 001-38174 21917267 34 126047
2021-04-16 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-04-16 16:00:00 9999999995-21-001468 333-255005 21832971 33 1902
2021-04-16 424B3 PROSPECTUS 0001213900-21-021932 333-255005 21832372 33 215698
2021-04-12 CORRESP filename1.htm 0001213900-21-021185 9378
2021-04-12 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-21-021184 001-38174 21820859 34 441911
2021-04-12 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-21-021181 001-38174 21820779 34 1151545
2021-04-09 UPLOAD filename1.pdf 0000000000-21-004294 40609
2021-04-02 S-3 REGISTRATION STATEMENT 0001213900-21-019952 333-255005 21802145 33 966822
2021-04-01 424B3 PROSPECTUS SUPPLEMENT 0001213900-21-019647 333-230919 21798161 33 59667
2021-03-26 424B3 PROSPECTUS SUPPLEMENT 0001213900-21-017994 333-230919 21777598 33 70561
2021-03-12 PRE 14A PRELIMINARY PROXY STATEMENT 0001213900-21-015112 001-38174 21737431 34 1153669
2021-03-12 SEC STAFF LETTER filename1.pdf 9999999997-21-000667 275482
2021-02-19 8-K CURRENT REPORT 1.01,3.02,8.01,9.01 0001213900-21-010620 001-38174 21656990 34 515609
2021-02-18 4 xslF345X03/ownership.xml 0001213900-21-010321 14913
2021-02-18 4 xslF345X03/ownership.xml 0001213900-21-010320 13771
2021-02-18 4 OWNERSHIP DOCUMENT 0001213900-21-010319 14945
2021-02-18 4 xslF345X03/ownership.xml 0001213900-21-010318 14939
2021-02-18 4 xslF345X03/ownership.xml 0001213900-21-010316 14929
2021-02-18 424B5 PROSPECTUS SUPPLEMENT 0001213900-21-010180 333-248748 21647461 33 389495
2021-02-16 S-3MEF REGISTRATION STATEMENT 0001213900-21-009819 333-253179 21642076 33 75291
2021-02-16 SC 13G/A d8805049_13g-a.htm 0000919574-21-001515 005-90253 21636700 34 88210
2021-02-16 8-K FORM 8-K 7.01,8.01,9.01 0001213900-21-009291 001-38174 21633234 34 21298956
2021-02-11 10-Q QUARTERLY REPORT 0001213900-21-008453 001-38174 21619616 34 2297260 1
2021-02-11 SEC STAFF LETTER filename1.pdf 9999999997-21-000466 276419
2021-02-09 8-K CURRENT REPORT 5.07 0001213900-21-007735 001-38174 21606366 34 29562
2021-02-05 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-02-05 17:00:00 9999999995-21-000477 333-252561 21598378 33 1902
2021-02-05 424B3 PROSPECTUS 0001213900-21-007164 333-252561 21597224 33 170184
2021-02-03 CORRESP filename1.htm 0001213900-21-006423 9304
2021-02-03 UPLOAD filename1.pdf 0000000000-21-001410 40416
2021-02-01 D xslFormDX01/primary_doc.xml 06b 0001213900-21-005652 021-387992 21575744 33 12814
2021-01-29 S-3 REGISTRATION STATEMENT 0001213900-21-005368 333-252561 21571232 33 265364
2021-01-27 8-K CURRENT REPORT 1.01,3.02,8.01,9.01 0001213900-21-004622 001-38174 21559904 34 707698
2021-01-11 8-K CURRENT REPORT 8.01,9.01 0001213900-21-001319 001-38174 21519348 34 15542315
2020-12-21 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-20-043795 001-38174 201404422 34 1600227
2020-12-21 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-20-043792 001-38174 201404409 34 927966
2020-12-16 10-K ANNUAL REPORT 0001213900-20-043004 001-38174 201392479 34 4414796 1
2020-12-09 8-K CURRENT REPORT 8.01,9.01 0001213900-20-041804 001-38174 201378003 34 40847
2020-12-08 8-K CURRENT REPORT 8.01,9.01 0001213900-20-041492 001-38174 201374519 34 38428
2020-11-30 8-K CURRENT REPORT 8.01,9.01 0001213900-20-039812 001-38174 201356537 34 36440
2020-10-26 8-K CURRENT REPORT 8.01,9.01 0001213900-20-033152 001-38174 201259122 34 215912
2020-10-09 8-K CURRENT REPORT 1.01,9.01 0001213900-20-030802 001-38174 201233349 34 62015
2020-10-09 4 OWNERSHIP DOCUMENT 0001213900-20-030797 13603
2020-10-09 4 xslF345X03/ownership.xml 0001213900-20-030795 12429
2020-10-09 4 OWNERSHIP DOCUMENT 0001213900-20-030794 16908
2020-10-09 4 OWNERSHIP DOCUMENT 0001213900-20-030793 28271
2020-10-09 4 OWNERSHIP DOCUMENT 0001213900-20-030792 12716
2020-10-09 4 xslF345X03/ownership.xml 0001213900-20-030791 13571
2020-10-09 4 OWNERSHIP DOCUMENT 0001213900-20-030790 13624
2020-10-09 4 OWNERSHIP DOCUMENT 0001213900-20-030788 13614
2020-09-30 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001213900-20-028494,2020-09-30 9999999995-20-002620 333-221492 201214150 33 1916
2020-09-29 8-K CURRENT REPORT 8.01,9.01 0001213900-20-028857 001-38174 201209028 34 30367
2020-09-25 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2020-09-25 16:00:00 9999999995-20-002581 333-248748 201201889 33 1903
2020-09-25 POS AM POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 0001213900-20-028494 333-221492 201200868 33 31357
2020-09-25 424B3 PROSPECTUS 0001213900-20-028490 333-248748 201200809 33 362065
2020-09-22 8-K CURRENT REPORT 8.01,9.01 0001213900-20-027841 001-38174 201189824 34 43157
2020-09-18 CORRESP filename1.htm 0001213900-20-027371 15061
2020-09-18 UPLOAD filename1.pdf 0000000000-20-008820 40501
2020-09-15 8-K CURRENT REPORT 8.01,9.01 0001213900-20-026724 001-38174 201176149 34 29527
2020-09-11 S-3 REGISTRATION STATEMENT 0001213900-20-026248 333-248748 201171158 33 1072770
2020-08-26 8-K CURRENT REPORT 8.01,9.01 0001213900-20-023818 001-38174 201137351 34 46369
2020-08-26 8-K CURRENT REPORT 8.01,9.01 0001213900-20-023749 001-38174 201134216 34 12899653
2020-08-14 10-Q QUARTERLY REPORT 0001213900-20-022331 001-38174 201106527 34 3180104 1
2020-08-10 8-K CURRENT REPORT 1.01,8.01,9.01 0001213900-20-021164 001-38174 201089519 34 417175
2020-08-07 424B5 PROSPECTUS SUPPLEMENT 0001213900-20-020900 333-221492 201085311 33 634046
2020-08-06 FWP FREE WRITING PROSPECTUS 0001213900-20-020467 333-221492 201079496 34 12463
2020-08-05 FWP FREE WRITING PROSPECTUS 0001213900-20-020409 333-221492 201078491 34 11987
2020-08-05 424B5 PROSPECTUS SUPPLEMENT 0001213900-20-020405 333-221492 201078475 33 642149
2020-08-04 8-K FORM 8-K 8.01,9.01 0001213900-20-020036 001-38174 201071394 34 30046
2020-07-15 4 xslF345X03/ownership.xml 0001213900-20-017558 5744
2020-07-15 3 xslF345X02/ownership.xml 0001213900-20-017556 10230
2020-07-14 8-K CURRENT REPORT 5.02,9.01 0001213900-20-017402 001-38174 201026446 34 34939
2020-07-10 8-K CURRENT REPORT 3.01 0001213900-20-017179 001-38174 201022705 34 18170
2020-07-09 4 xslF345X03/ownership.xml 0001213900-20-017089 12239
2020-07-09 4 xslF345X03/ownership.xml 0001213900-20-017086 12244
2020-07-09 4 xslF345X03/ownership.xml 0001213900-20-017083 12233
2020-07-09 4 xslF345X03/ownership.xml 0001213900-20-017080 11089
2020-07-09 4 xslF345X03/ownership.xml 0001213900-20-017075 12233
2020-06-26 8-K CURRENT REPORT 8.01,9.01 0001213900-20-015902 001-38174 20991361 34 32852
2020-06-12 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2020-06-12 16:00:00 9999999995-20-001419 333-238975 20961808 33 1902
2020-06-12 424B3 PROSPECTUS 0001213900-20-014875 333-238975 20961111 33 458173
2020-06-11 CORRESP filename1.htm 0001213900-20-014691 9707
2020-06-11 UPLOAD filename1.pdf 0000000000-20-005207 40440
2020-06-05 S-1 REGISTRATION STATEMENT 0001213900-20-014231 333-238975 20946721 33 621166
2020-06-02 8-K FORM 8-K 8.01,9.01 0001213900-20-013937 001-38174 20937510 34 28507
2020-05-26 8-K CURRENT REPORT 8.01,9.01 0001213900-20-013443 001-38174 20910652 34 29552
2020-05-19 D xslFormDX01/primary_doc.xml 06b 0001213900-20-012897 021-367265 20892515 33 12606
2020-05-18 8-K CURRENT REPORT 1.01,3.02,8.01,9.01 0001213900-20-012809 001-38174 20889629 34 555455
2020-05-15 424B5 PROSPECTUS SUPPLEMENT 0001213900-20-012584 333-221492 20885023 33 393910
2020-05-14 10-Q QUARTERLY REPORT 0001213900-20-012286 001-38174 20878193 34 2387421 1
2020-05-12 8-K FORM 8-K 8.01,9.01 0001213900-20-011769 001-38174 20867153 34 218897
2020-04-29 8-K CURRENT REPORT 8.01,9.01 0001213900-20-010431 001-38174 20830267 34 13588358
2020-04-28 8-K CURRENT REPORT 8.01,9.01 0001213900-20-010246 001-38174 20822438 34 35025
2020-04-24 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2020-04-24 15:00:00 9999999995-20-000856 333-237638 20817060 33 1902
2020-04-24 424B3 PROSPECTUS SUPPLEMENT 0001213900-20-010056 333-237638 20815917 33 506418
2020-04-17 CORRESP filename1.htm 0001213900-20-009473 9536
2020-04-16 UPLOAD filename1.pdf 0000000000-20-003314 46182
2020-04-10 S-1 REGISTRATION STATEMENT 0001213900-20-008985 333-237638 20786956 33 696766
2020-04-07 8-K CURRENT REPORT 3.01 0001213900-20-008765 001-38174 20779881 34 22930
2020-04-01 8-K CURRENT REPORT 5.05,8.01,9.01 0001213900-20-008291 001-38174 20763818 34 35213
2020-02-25 8-K FORM 8-K 8.01,9.01 0001213900-20-004698 001-38174 20647602 34 35313
2020-02-19 8-K CURRENTT REPORT 1.01,3.02,9.01 0001213900-20-004257 001-38174 20629960 34 363242
2020-02-18 424B3 PROSPECTUS SUPPLEMENT 0001213900-20-004160 333-230919 20626394 33 75591
2020-02-18 424B3 PROSPECTUS SUPPLEMENT 0001213900-20-004157 333-224386 20626378 33 43724
2020-02-14 8-K CURRENT REPORT 1.01,3.02 0001213900-20-003992 001-38174 20621606 34 24343
2020-02-14 SC 13G/A d8478261_13g-a.htm 0000919574-20-001645 005-90253 20618684 34 116953
2020-02-13 10-Q QUARTERLY REPORT 0001213900-20-003577 001-38174 20610754 34 2416346 1
2020-02-10 8-K CURRENT REPORT 5.07 0001213900-20-003094 001-38174 20591905 34 33065
2020-02-06 SC 13G/A d8473989_13g-a.htm 0000919574-20-000776 005-90253 20582391 34 124712
2020-02-04 8-K CURRENT REPORT 8.01,9.01 0001213900-20-002480 001-38174 20570855 34 34213
2020-02-03 8-K CURRENT REPORT 3.01,9.01 0001213900-20-002349 001-38174 20567069 34 39382
2020-01-22 8-K CURRENT REPORT 8.01,9.01 0001213900-20-001566 001-38174 20539413 34 8227028
2019-12-20 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-19-026703 001-38174 191302028 34 2089485
2019-12-20 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-19-026699 001-38174 191301997 34 1627886
2019-12-19 8-K CURRENT REPORT 8.01,9.01 0001213900-19-026521 001-38174 191294229 34 31199
2019-12-16 S-8 REGISTRATION STATEMENT 0001213900-19-026269 333-235535 191287567 33 115999
2019-12-16 10-K ANNUAL REPORT 0001213900-19-026259 001-38174 191287420 34 4166895 1
2019-11-05 8-K CURRENT REPORT 8.01,9.01 0001213900-19-022028 001-38174 191192296 34 121684
2019-11-01 8-K CURRENT REPORT 3.01 0001213900-19-021804 001-38174 191186867 34 21537
2019-10-10 4 xslF345X03/ownership.xml 0001213900-19-020126 10896
2019-10-10 4 xslF345X03/ownership.xml 0001213900-19-020124 10895
2019-10-10 4 xslF345X03/ownership.xml 0001213900-19-020122 31590
2019-10-10 4 xslF345X03/ownership.xml 0001213900-19-020119 10895
2019-10-10 4 xslF345X03/ownership.xml 0001213900-19-020117 10906
2019-10-10 4 xslF345X03/ownership.xml 0001213900-19-020115 16534
2019-10-10 4 xslF345X03/ownership.xml 0001213900-19-020113 9751
2019-10-10 4 xslF345X03/ownership.xml 0001213900-19-020111 11112
2019-10-07 8-K CURRENT REPORT 8.01,9.01 0001213900-19-019843 001-38174 191139774 34 45549
2019-09-27 8-K FORM 8-K 1.01,8.01,9.01 0001213900-19-019191 001-38174 191122501 34 632674
2019-09-27 4 xslF345X03/ownership.xml 0001213900-19-019180 30943
2019-09-27 4 xslF345X03/ownership.xml 0001213900-19-019177 15885
2019-09-26 424B4 PROSPECTUS 0001213900-19-019012 333-233759 191118265 33 417198
2019-09-24 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2019-09-24 17:15:00 9999999995-19-002163 333-233759 191111937 33 1903
2019-09-20 CORRESP filename1.htm 0001213900-19-018549 12695
2019-09-20 CORRESP filename1.htm 0001213900-19-018542 8168
2019-09-20 S-1/A AMENDMENT NO. 1 TO FORM S-1 0001213900-19-018533 333-233759 191105090 33 1345962
2019-09-19 8-K CURRENT REPORT 8.01,9.01 0001213900-19-018453 001-38174 191102115 34 14886940
2019-09-19 UPLOAD filename1.pdf 0000000000-19-013747 40110
2019-09-13 S-1 REGISTRATION STATEMENT 0001213900-19-017988 333-233759 191092993 33 713730
2019-09-04 8-K FORM 8-K 8.01,9.01 0001213900-19-017183 001-38174 191073370 34 28574
2019-08-14 10-Q QUARTERLY REPORT 0001213900-19-015793 001-38174 191026284 34 2352598 1
2019-05-28 SC 13G d8234394_13-g.htm 0000919574-19-003846 005-90253 19856959 34 109494
2019-05-15 10-Q QUARTERLY REPORT 0001213900-19-008833 001-38174 19828635 34 2209828 1
2019-04-30 8-K CURRENT REPORT 8.01,9.01 0001213900-19-007374 001-38174 19778919 34 48133
2019-04-26 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2019-04-26 16:00:00 9999999995-19-000862 333-230919 19773542 33 1902
2019-04-26 424B3 PROSPECTUS SUPPLEMENT 0001213900-19-007217 333-230919 19772383 33 523019
2019-04-24 CORRESP filename1.htm 0001213900-19-007037 10545
2019-04-23 UPLOAD filename1.pdf 0000000000-19-007488 46190
2019-04-17 S-1 REGISTRATION STATEMENT 0001213900-19-006592 333-230919 19753382 33 713012
2019-04-08 D xslFormDX01/primary_doc.xml 06b 0001213900-19-005961 021-336699 19737154 33 12599
2019-04-05 4 xslF345X03/ownership.xml 0001213900-19-005844 29635
2019-04-05 4 xslF345X03/ownership.xml 0001213900-19-005843 14580
2019-04-03 8-K f8k040119_citiupharma.htm 1.01,3.02,8.01,9.01 0001213900-19-005717 001-38174 19729424 34 581732
2019-04-01 424B5 PROSPECTUS SUPPLEMENT 0001213900-19-005489 333-221492 19721082 33 373733

Latest XBRL company facts

One latest value per concept from companyfacts (436 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 27.45M 2026-08-13 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
dei EntityPublicFloat Entity Public Float USD 11.39M 2025-03-31 2025 FY 10-K/A 2026-01-28 0001213900-26-008861
ffd NetFeeAmt NetFeeAmt USD 396.05 2026-05-18 S-3 2026-05-22 0001213900-26-060644
ffd TtlFeeAmt TtlFeeAmt USD 396.05 2026-05-18 S-3 2026-05-22 0001213900-26-060644
ffd TtlOfferingAmt TtlOfferingAmt USD 2.87M 2026-05-18 S-3 2026-05-22 0001213900-26-060644
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-05-18 S-3 2026-05-22 0001213900-26-060644
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-05-18 S-3 2026-05-22 0001213900-26-060644
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 8.04M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap AccountsPayableOtherCurrentAndNoncurrent Accounts Payable, Other USD 2.20M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap AccountsPayableRelatedPartiesCurrent Accounts Payable, Related Parties, Current USD 0 2013-09-30 2013 FY 10-K 2014-02-06 0001185185-14-000261
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 686,235 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 25.91M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 8,930 2018-06-30 2018 Q3 10-Q 2018-08-14 0001213900-18-011072
us-gaap AcquisitionCosts Acquisition Costs, Period Cost USD 19.02M 2017-10-01 2018-03-31 2018 Q2 10-Q 2018-05-11 0001213900-18-005952
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 343.70M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap AdjustmentsToAdditionalPaidInCapitalMarkToMarket Adjustments to Additional Paid in Capital, Fair Value USD -1.43M 2016-10-01 2017-06-30 2017 Q3 10-Q 2017-08-14 0001477932-17-003946
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD -62,764 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 10.84M 2024-10-01 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition USD 297,998 2016-10-01 2017-09-30 2019 FY 10-K 2019-12-16 0001213900-19-026259
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 3.83M 2023-10-01 2024-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 68,597 2025-10-01 2025-12-31 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 3.37M 2025-10-01 2026-03-31 2026 Q2 10-Q 2026-05-15 0001213900-26-057842
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 0 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 833,333 2016-10-01 2017-09-30 2019 FY 10-K 2019-12-16 0001213900-19-026259
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 179,492 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap Assets Assets USD 142.26M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap AssetsCurrent Assets, Current USD 43.33M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 0 2013-09-30 2013 FY 10-K 2014-02-06 0001185185-14-000261
us-gaap AuctionMarketPreferredSecuritiesStockSeriesParValuePerShare Auction Market Preferred Securities, Stock Series, Par Value Per Share USD/shares 1 2024-03-12 2024 Q3 10-Q 2024-08-12 0001213900-24-067732
us-gaap BankOverdrafts Bank Overdrafts USD 0 2014-06-30 2014 Q3 10-Q 2014-08-14 0001185185-14-002170
us-gaap BasicEarningsPerShareAdjustmentProForma Basic Earnings Per Share Adjustment, Pro Forma USD/shares -2.52 2015-10-01 2016-09-30 2018 FY 10-K 2018-12-11 0001213900-18-017214
us-gaap BusinessAcquisitionCostOfAcquiredEntityTransactionCosts Business Acquisition, Transaction Costs USD 2.36M 2024-08-12 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap BusinessAcquisitionsProFormaNetIncomeLoss Business Acquisition, Pro Forma Net Income (Loss) USD -11.55M 2015-10-01 2016-09-30 2018 FY 10-K 2018-12-11 0001213900-18-017214
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents USD 163,500 2024-08-12 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities USD 559,015 2024-08-12 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net USD 395,515 2024-08-12 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 28.40M 2023-10-01 2024-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap CapitalLeasesLesseeBalanceSheetAssetsByMajorClassPropertyPlantAndEquipmentOtherAccumulatedDepreciation Capital Leases, Lessee Balance Sheet, Assets by Major Class, Property, Plant, and Equipment Other, Accumulated Depreciation USD 4,780 2016-09-30 2016 FY 10-K 2016-12-23 0001477932-16-014315
us-gaap Cash Cash USD 51.00M 2024-03-31 2024 Q2 10-Q 2024-05-14 0001213900-24-042920
us-gaap CashAcquiredFromAcquisition Cash Acquired from Acquisition USD 255,748 2015-10-01 2016-09-30 2018 FY 10-K 2018-12-11 0001213900-18-017214
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 17.01M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -3.55M 2019-10-01 2020-03-31 2020 Q2 10-Q 2020-05-14 0001213900-20-012286
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 17.01M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 12.76M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap CashPeriodIncreaseDecrease Cash, Period Increase (Decrease) USD 65 2010-09-01 2011-06-30 2011 Q3 10-Q 2011-08-26 0001019687-11-002825
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 3.91 2024-12-31 2025 Q1 10-Q 2025-02-14 0001213900-25-014321
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight Class of Warrant or Right, Number of Securities Called by Each Warrant or Right shares 7,577 2025-08-07 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 5.14M 2025-09-10 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 17.62M 2025-06-30 2025 Q3 10-Q 2025-08-12 0001213900-25-074997
us-gaap ClassOfWarrantOrRightUnissued Class of Warrant or Right, Unissued shares 140,819 2017-06-08 2019 FY 10-K 2019-12-16 0001213900-19-026259
us-gaap CommercialPaper Commercial Paper USD 300.00M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 98.13M 2024-06-30 2024 Q3 10-Q 2024-08-12 0001213900-24-067732
us-gaap CommonStockDividendsPerShareCashPaid Common Stock, Dividends, Per Share, Cash Paid USD/shares 0.6 2015-10-01 2016-09-30 2016 FY 10-K 2016-12-23 0001477932-16-014315
us-gaap CommonStockNoParValue Common Stock, No Par Value USD/shares 0.001 2017-06-09 2017 FY 10-K 2017-12-13 0001213900-17-013191
us-gaap CommonStockOtherSharesOutstanding Common Stock, Other Shares, Outstanding shares 5.00M 2014-09-12 2016 FY 10-K 2016-12-23 0001477932-16-014315
us-gaap CommonStockOtherValueOutstanding Common Stock, Other Value, Outstanding USD 31.13M 2021-09-30 2022 FY 10-K 2022-12-22 0001213900-22-082217
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 250.00M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 27.45M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 27.45M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap CommonStockValue Common Stock, Value, Issued USD 27,452 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap CompensatedAbsencesLiability Compensated Absences Liability USD 615,000 2016-03-31 2016 Q2 10-Q 2016-05-20 0001477932-16-010490
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 68,970 2017-10-01 2017-12-31 2018 Q1 10-Q 2018-02-14 0001213900-18-001880
us-gaap ConvertibleNotesPayable Convertible Notes Payable USD 1.69M 2013-12-31 2014 FY 10-KT 2014-12-29 0001477932-14-007353
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 100,000 2016-12-14 2016 FY 10-K 2016-12-23 0001477932-16-014315
us-gaap ConvertiblePreferredStockSharesReservedForFutureIssuance Convertible Preferred Stock, Shares Reserved for Future Issuance shares 12.00M 2022-12-31 2023 Q1 10-Q 2023-02-10 0001213900-23-010315
us-gaap ConvertibleSubordinatedDebtCurrent Convertible Subordinated Debt, Current USD 350,000 2013-12-31 2014 FY 10-KT 2014-12-29 0001477932-14-007353
us-gaap CostMaintenance Cost, Maintenance USD 75,000 2023-01-01 2023-01-31 2023 Q3 10-Q 2023-08-14 0001213900-23-067024
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 75,000 2017-10-01 2018-09-30 2019 FY 10-K 2019-12-16 0001213900-19-026259
us-gaap CostOfRevenue Cost of Revenue USD 1.61M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 600,000 2013-11-01 2013-11-30 2016 FY 10-K 2016-12-23 0001477932-16-014315
us-gaap DebtConversionConvertedInstrumentRate Debt Conversion, Converted Instrument, Rate pure 0.05 2013-11-01 2013-11-30 2016 FY 10-K 2016-12-23 0001477932-16-014315
us-gaap DebtInstrumentAnnualPrincipalPayment Debt Instrument, Annual Principal Payment USD 25,000 2019-01-02 2020 Q2 10-Q 2020-05-14 0001213900-20-012286
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 600,000 2014-09-30 2015 FY 10-K 2015-12-14 0001477932-15-007617
us-gaap DebtInstrumentConvertibleBeneficialConversionFeature Debt Instrument, Convertible, Beneficial Conversion Feature USD 1.60M 2016-10-01 2017-09-30 2019 FY 10-K 2019-12-16 0001213900-19-026259
us-gaap DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price USD/shares 0.65 2016-09-30 2016 FY 10-K 2016-12-23 0001477932-16-014315
us-gaap DebtInstrumentDecreaseForgiveness Debt Instrument, Decrease, Forgiveness USD 10 2013-10-01 2014-06-30 2014 Q3 10-Q 2014-08-14 0001185185-14-002170
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 8.00M 2026-05-05 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.01 2019-09-30 2019 FY 10-K 2019-12-16 0001213900-19-026259
us-gaap DebtInstrumentPeriodicPaymentPrincipal Debt Instrument, Periodic Payment, Principal USD 2.50M 2018-10-01 2019-09-30 2019 FY 10-K 2019-12-16 0001213900-19-026259
us-gaap DebtIssuanceCosts Debt Issuance Cost (Deprecated 2016-01-31) USD -42,000 2013-01-01 2013-12-31 2015 FY 10-K 2015-12-14 0001477932-15-007617
us-gaap DebtRelatedCommitmentFeesAndDebtIssuanceCosts Debt Related Commitment Fees and Debt Issuance Costs USD -42,000 2013-01-01 2013-12-31 2014 FY 10-KT 2014-12-29 0001477932-14-007353
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 169,252 2026-03-31 2026 Q2 10-Q 2026-05-15 0001213900-26-057842
us-gaap DeferredCostsCurrentAndNoncurrent Deferred Costs USD 749,280 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 576,000 2022-10-01 2023-09-30 2023 FY 10-K 2023-12-29 0001213900-23-099889
us-gaap DeferredFinanceCostsNet Debt Issuance Costs, Net USD 14,000 2013-12-31 2014 FY 10-KT 2014-12-29 0001477932-14-007353
us-gaap DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment Deferred Finance Costs, Own-share Lending Arrangement, Issuance Costs, Adjustment USD 25,000 2013-01-01 2013-12-31 2015 FY 10-K 2015-12-14 0001477932-15-007617
us-gaap DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsNet Deferred Finance Costs, Own-share Lending Arrangement, Issuance Costs, Net USD 25,000 2013-12-31 2016 FY 10-K 2016-12-23 0001477932-16-014315
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD -74,317 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 7.99M 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap DeferredIncomeTaxLiabilitiesNet Deferred Income Tax Liabilities, Net USD 7.70M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 64,801 2016-09-30 2017 FY 10-K 2017-12-13 0001213900-17-013191
us-gaap DeferredRevenue Deferred Revenue USD 40.00M 2023-09-30 2023 FY 10-K 2023-12-29 0001213900-23-099889
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 6.70M 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2013-09-30 2013 FY 10-K 2014-02-06 0001185185-14-000261
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 224,000 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 48.99M 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 181.00M 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration USD 29.00M 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 6.42M 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 5.30M 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits USD 189,000 2014-09-30 2014 FY 10-KT 2014-12-29 0001477932-14-007353
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 4.27M 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 66.15M 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 7.77M 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs USD 7.77M 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap DepositLiabilitiesAccruedInterest Deposit Liabilities, Accrued Interest USD 23,862 2016-03-31 2016 Q2 10-Q 2016-05-20 0001477932-16-010490
us-gaap Deposits Deposits USD -2,167 2016-03-31 2016 Q2 10-Q 2016-05-20 0001477932-16-010490
us-gaap DepositsAssets Deposits Assets USD 38,062 2024-06-30 2024 Q3 10-Q 2024-08-12 0001213900-24-067732
us-gaap DepositsAssetsNoncurrent Deposits Assets, Noncurrent USD 38,062 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap Depreciation Depreciation USD 1,432 2023-10-01 2024-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 2,632 2016-10-01 2017-09-30 2017 FY 10-K 2017-12-13 0001213900-17-013191
us-gaap DerivativeAssetsLiabilitiesAtFairValueNet Derivative Assets (Liabilities), at Fair Value, Net USD 1.68M 2016-09-30 2018 FY 10-K 2018-12-11 0001213900-18-017214
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD -1.45M 2020-10-01 2021-09-30 2022 FY 10-K 2022-12-22 0001213900-22-082217
us-gaap DerivativeLiabilities Derivative Liability USD 581,164 2017-06-30 2017 Q3 10-Q 2017-08-14 0001477932-17-003946
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 1.68M 2016-09-30 2017 FY 10-K 2017-12-13 0001213900-17-013191
us-gaap DevelopmentInProcess Development in Process USD 22.00M 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) USD 111,883 2014-06-30 2014 Q3 10-Q 2014-08-14 0001185185-14-002170
us-gaap DiscontinuedOperationAmountOfAdjustmentToPriorPeriodGainLossOnDisposalBeforeIncomeTax Discontinued Operation, Amount of Adjustment to Prior Period Gain (Loss) on Disposal, before Income Tax USD 2.39M 2023-10-01 2024-09-30 2024 FY 10-K 2024-12-27 0001213900-24-113149
us-gaap Dividends Dividends USD 350,241 2024-09-25 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap DividendsCommonStockPaidinkind Dividends, Common Stock, Paid-in-kind USD 1.45M 2020-10-01 2021-09-30 2022 FY 10-K 2022-12-22 0001213900-22-082217
us-gaap DividendsCommonStockStock Dividends, Common Stock, Stock USD 1.29M 2021-04-30 2022 FY 10-K 2022-12-22 0001213900-22-082217
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 27,637 2017-09-30 2018 FY 10-K 2018-12-11 0001213900-18-017214
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -1.64 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.06 2021-10-01 2021-12-31 2022 Q1 10-Q 2022-02-10 0001213900-22-006429
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -1.64 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.027 2024-10-01 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure -0.052 2014-01-01 2014-09-30 2014 FY 10-KT 2014-12-29 0001477932-14-007353
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure 0.26 2024-10-01 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure -0.35 2014-10-01 2015-09-30 2015 FY 10-K 2015-12-14 0001477932-15-007617
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0.04 2024-10-01 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure -0.046 2014-10-01 2015-09-30 2015 FY 10-K 2015-12-14 0001477932-15-007617
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure 0.266 2019-10-01 2020-09-30 2020 FY 10-K 2020-12-16 0001213900-20-043004
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.063 2024-10-01 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure 0 2014-10-01 2015-09-30 2015 FY 10-K 2015-12-14 0001477932-15-007617
us-gaap EffectiveIncomeTaxRateReconciliationTaxExemptIncome Effective Income Tax Rate Reconciliation, Tax Exempt Income, Percent pure 0.21 2024-10-01 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 2.19M 2022-10-01 2023-09-30 2023 FY 10-K 2023-12-29 0001213900-23-099889
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 1.87M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 213,444 2020-12-31 2021 Q1 10-Q 2021-02-11 0001213900-21-008453
us-gaap EquityIssuancePerShareAmount Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) USD 0.001 2009-10-01 2010-09-30 2014 Q2 10-Q 2014-05-15 0001185185-14-001283
us-gaap EquityIssuedInBusinessCombinationFairValueDisclosure Equity Issued in Business Combination, Fair Value Disclosure USD 67.50M 2024-06-30 2024 Q3 10-Q 2024-08-12 0001213900-24-067732
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 11.00M 2023-05-08 2023 FY 10-K 2023-12-29 0001213900-23-099889
us-gaap FairValueAssumptionsExpectedDividendRate Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) pure 0 2015-10-01 2016-09-30 2016 FY 10-K 2016-12-23 0001477932-16-014315
us-gaap FairValueAssumptionsExpectedVolatilityRate Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) pure 0.85 2016-10-01 2017-03-31 2018 Q2 10-Q 2018-05-11 0001213900-18-005952
us-gaap FairValueAssumptionsRiskFreeInterestRate Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) pure 0.02 2016-10-01 2017-03-31 2018 Q2 10-Q 2018-05-11 0001213900-18-005952
us-gaap FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss Fair Value, Net Derivative Asset (Liability), Recurring Basis, Still Held, Unrealized Gain (Loss) USD 452,147 2016-10-01 2017-09-30 2019 FY 10-K 2019-12-16 0001213900-19-026259
us-gaap FinanceLeaseInterestExpense Finance Lease, Interest Expense USD 66,512 2019-10-01 2020-06-30 2020 Q3 10-Q 2020-08-14 0001213900-20-022331
us-gaap GainLossOnSaleOfInvestments Gain (Loss) on Sale of Investments USD 3.83M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 2.39M 2023-10-01 2024-09-30 2024 FY 10-K 2024-12-27 0001213900-24-113149
us-gaap GainsLossesOnRestructuringOfDebt Gains (Losses) on Restructuring of Debt USD 166,557 2020-10-01 2021-09-30 2022 FY 10-K 2022-12-22 0001213900-22-082217
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 38.26M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap Goodwill Goodwill USD 9.35M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap GoodwillGross Goodwill, Gross USD 9.35M 2023-09-30 2023 FY 10-K 2023-12-29 0001213900-23-099889
us-gaap GoodwillPurchaseAccountingAdjustments Goodwill, Purchase Accounting Adjustments USD 1.59M 2016-03-01 2016-03-30 2019 FY 10-K 2019-12-16 0001213900-19-026259
us-gaap GrossProfit Gross Profit USD 5.50M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -49.50M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -16,667 2013-10-01 2014-06-30 2014 Q3 10-Q 2014-08-14 0001185185-14-002170
us-gaap IncomeLossFromContinuingOperationsPerBasicShare Income (Loss) from Continuing Operations, Per Basic Share USD/shares -0.17 2023-10-01 2024-06-30 2024 Q3 10-Q 2024-08-12 0001213900-24-067732
us-gaap IncomeLossFromContinuingOperationsPerDilutedShare Income (Loss) from Continuing Operations, Per Diluted Share USD/shares -0.17 2023-10-01 2024-06-30 2024 Q3 10-Q 2024-08-12 0001213900-24-067732
us-gaap IncomeLossFromEquityMethodInvestments Income (Loss) from Equity Method Investments USD 110,207 2019-10-01 2020-09-30 2021 FY 10-K 2021-12-15 0001213900-21-065464
us-gaap IncomeTaxesPaid Income Taxes Paid USD 0 2013-10-01 2014-06-30 2014 Q3 10-Q 2014-08-14 0001185185-14-002170
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD -74,317 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 44.91M 2022-10-01 2023-09-30 2023 FY 10-K 2023-12-29 0001213900-23-099889
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -5.66M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap IncreaseDecreaseInAccountsPayableRelatedParties Increase (Decrease) in Accounts Payable, Related Parties USD 387 2010-09-01 2011-06-30 2011 Q3 10-Q 2011-08-26 0001019687-11-002825
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 686,235 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap IncreaseDecreaseInAccruedInterestReceivableNet Increase (Decrease) in Accrued Interest Receivable, Net USD -394,732 2022-10-01 2023-09-30 2023 FY 10-K 2023-12-29 0001213900-23-099889
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 19.96M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap IncreaseDecreaseInAccruedSalaries Increase (Decrease) in Accrued Salaries USD -143,749 2021-10-01 2022-09-30 2022 FY 10-K 2022-12-22 0001213900-22-082217
us-gaap IncreaseDecreaseInDeposits Increase (Decrease) in Deposits USD -54,926 2018-10-01 2019-09-30 2019 FY 10-K 2019-12-16 0001213900-19-026259
us-gaap IncreaseDecreaseInDueFromRelatedParties Increase (Decrease) in Due from Related Parties USD 281 2014-01-01 2014-09-30 2014 FY 10-KT 2014-12-29 0001477932-14-007353
us-gaap IncreaseDecreaseInDueFromRelatedPartiesCurrent Increase (Decrease) in Due from Related Parties, Current USD -1,775 2015-10-01 2016-03-31 2016 Q2 10-Q 2016-05-20 0001477932-16-010490
us-gaap IncreaseDecreaseInDueToRelatedParties Increase (Decrease) in Due to Related Parties USD -27,637 2017-10-01 2018-09-30 2019 FY 10-K 2019-12-16 0001213900-19-026259
us-gaap IncreaseDecreaseInDueToRelatedPartiesCurrent Increase (Decrease) in Due to Related Parties, Current USD 2,287 2010-09-09 2014-03-31 2014 Q2 10-Q 2014-05-15 0001185185-14-001283
us-gaap IncreaseDecreaseInEmployeeRelatedLiabilities Increase (Decrease) in Employee Related Liabilities USD -1.42M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap IncreaseDecreaseInInterestPayableNet Increase (Decrease) in Interest Payable, Net USD 663 2013-10-01 2014-06-30 2014 Q3 10-Q 2014-08-14 0001185185-14-002170
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 339,252 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap IncreaseDecreaseInNotesReceivables Increase (Decrease) in Notes Receivables USD 1.08M 2025-10-01 2026-03-31 2026 Q2 10-Q 2026-05-15 0001213900-26-057842
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -46,316 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap IncreaseDecreaseInOtherReceivables Increase (Decrease) in Other Receivables USD -818,343 2018-10-01 2019-09-30 2020 FY 10-K 2020-12-16 0001213900-20-043004
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 1.62M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap IncreaseDecreaseInSelfInsuranceReserve Increase (Decrease) in Self Insurance Reserve USD 315,115 2016-10-01 2017-06-30 2017 Q3 10-Q 2017-08-14 0001477932-17-003946
us-gaap IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements Incremental Common Shares Attributable to Dilutive Effect of Equity Unit Purchase Agreements shares 201,334 2019-10-01 2020-03-31 2020 Q2 10-Q 2020-05-14 0001213900-20-012286
us-gaap IndefiniteLivedTrademarks Indefinite-Lived Trademarks USD 5,401 2015-09-30 2016 FY 10-K 2016-12-23 0001477932-16-014315
us-gaap IntangibleAssetsCurrent Intangible Assets, Current USD 19.40M 2016-03-30 2019 FY 10-K 2019-12-16 0001213900-19-026259
us-gaap InterestAndDebtExpense Interest and Debt Expense USD 112,270 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap InterestAndOtherIncome Interest and Other Income USD 38,917 2021-06-01 2021-06-30 2022 FY 10-K 2022-12-22 0001213900-22-082217
us-gaap InterestExpense Interest Expense USD 198,333 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap InterestExpenseBorrowings Interest Expense, Borrowings USD 7,897 2017-10-01 2018-03-31 2018 Q2 10-Q 2018-05-11 0001213900-18-005952
us-gaap InterestExpenseDebt Interest Expense, Debt USD 49,750 2024-10-01 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 420,301 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap InterestExpenseOther Interest Expense, Other USD 218,032 2024-10-01 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap InterestExpenseRelatedParty Interest Expense, Related Party USD 9,606 2020-10-01 2021-09-30 2022 FY 10-K 2022-12-22 0001213900-22-082217
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD 800 2015-10-01 2016-06-30 2017 Q3 10-Q 2017-08-14 0001477932-17-003946
us-gaap InterestIncomeOther Interest Income, Other USD 59,917 2020-10-01 2021-09-30 2022 FY 10-K 2022-12-22 0001213900-22-082217
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 5 2018-10-01 2019-03-31 2020 Q2 10-Q 2020-05-14 0001213900-20-012286
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 303,644 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap InterestPayableCurrent Interest Payable, Current USD 89,970 2020-09-30 2021 FY 10-K 2021-12-15 0001213900-21-065464
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 15.67M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap InventoryGross Inventory, Gross USD 8.27M 2024-09-30 2024 FY 10-K 2024-12-27 0001213900-24-113149
us-gaap InventoryNet Inventory, Net USD 22.63M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 6.95M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 215,372 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 107,510 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 2,167 2015-10-01 2016-03-31 2016 Q2 10-Q 2016-05-20 0001477932-16-010490
us-gaap LeaseCost Lease, Cost USD 144,649 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap LegalFees Legal Fees USD 2.90M 2024-10-01 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 873,000 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 232,827 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 102,849 2026-03-31 2026 Q2 10-Q 2026-05-15 0001213900-26-057842
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 102,849 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 242,545 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 237,686 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 57,093 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 106,043 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap LeveragedLeasesNetInvestmentInLeveragedLeasesDisclosureInvestmentInLeveragedLeasesNet Leveraged Leases, Net Investment in Leveraged Leases Disclosure, Investment in Leveraged Leases, Net USD 1.03M 2020-06-30 2020 Q3 10-Q 2020-08-14 0001213900-20-022331
us-gaap Liabilities Liabilities USD 66.35M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 142.26M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap LiabilitiesCurrent Liabilities, Current USD 51.65M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap LiabilitiesFairValueDisclosureRecurring Liabilities, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) USD 0 2013-09-30 2013 FY 10-K 2014-02-06 0001185185-14-000261
us-gaap LicenseAndMaintenanceRevenue License and Maintenance Revenue (Deprecated 2018-01-31) USD 75,000 2017-10-01 2018-03-31 2018 Q2 10-Q 2018-05-11 0001213900-18-005952
us-gaap LongTermNotesPayable Notes Payable, Noncurrent USD 6.41M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap LongTermPurchaseCommitmentAmount Long-term Purchase Commitment, Amount USD 8.50M 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap MaintenanceCosts Maintenance Costs (Deprecated 2018-01-31) USD 50,000 2016-10-01 2017-09-30 2018 Q1 10-Q 2018-02-14 0001213900-18-001880
us-gaap ManagementFeeExpense Management Fee Expense USD 90,000 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap ManufacturingCosts Manufacturing Costs USD 1.20M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap MinorityInterest Stockholders' Equity Attributable to Noncontrolling Interest USD 9.30M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 42.74M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -7.00M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -22.99M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -11.51M 2025-01-01 2025-03-31 2025 Q2 10-Q 2025-05-14 0001213900-25-043360
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD -11.11M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -38.31M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 Noncash or Part Noncash Acquisition, Fixed Assets Acquired USD 1.37M 2024-10-01 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1 Noncash or Part Noncash Acquisition, Value of Assets Acquired USD 19.40M 2022-10-01 2023-06-30 2023 Q3 10-Q 2023-08-14 0001213900-23-067024
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 3.45M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap NotesAssumed1 Notes Assumed USD 160,470 2021-06-01 2021-06-30 2022 Q1 10-Q 2022-02-10 0001213900-22-006429
us-gaap NotesPayable Notes Payable USD 172,970 2021-06-30 2022 FY 10-K 2022-12-22 0001213900-22-082217
us-gaap NotesPayableCurrent Notes Payable, Current USD 1.00M 2025-09-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap NotesPayableRelatedPartiesClassifiedCurrent Notes Payable, Related Parties, Current USD 172,970 2020-09-30 2020 FY 10-K 2020-12-16 0001213900-20-043004
us-gaap NumberOfReportableSegments Number of Reportable Segments pure 1 2024-10-01 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap OperatingExpenses Operating Expenses USD 58.44M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -52.95M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap OperatingLeaseCost Operating Lease, Cost USD 144,251 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 48,532 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 766,957 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 176,170 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 590,787 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 753,039 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 214,250 2024-10-01 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 1.13M 2021-03-31 2021 Q2 10-Q 2021-05-13 0001213900-21-025920
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 117,830 2021-03-31 2021 Q2 10-Q 2021-05-13 0001213900-21-025920
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 275,343 2021-03-31 2021 Q2 10-Q 2021-05-13 0001213900-21-025920
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourAndFiveYears Operating Leases, Future Minimum Payments, Due in Four and Five Years USD 252,668 2019-06-30 2019 Q3 10-Q 2019-08-14 0001213900-19-015793
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 249,024 2021-03-31 2021 Q2 10-Q 2021-05-13 0001213900-21-025920
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 244,165 2021-03-31 2021 Q2 10-Q 2021-05-13 0001213900-21-025920
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 239,306 2021-03-31 2021 Q2 10-Q 2021-05-13 0001213900-21-025920
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 21,460 2020-09-30 2020 FY 10-K 2020-12-16 0001213900-20-043004
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 26,004 2017-09-30 2016 FY 10-K 2016-12-23 0001477932-16-014315
us-gaap OperatingLeasesRentExpenseMinimumRentals Operating Leases, Rent Expense, Minimum Rentals USD 2,167 2019-04-01 2019-04-30 2020 FY 10-K 2020-12-16 0001213900-20-043004
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 56,063 2019-10-01 2020-06-30 2020 Q3 10-Q 2020-08-14 0001213900-20-022331
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.08 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 152.00M 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap OperatingLossCarryforwardsValuationAllowance Operating Loss Carryforwards, Valuation Allowance USD 3.59M 2020-09-30 2020 FY 10-K 2020-12-16 0001213900-20-043004
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 4.10M 2023-09-30 2023 FY 10-K 2023-12-29 0001213900-23-099889
us-gaap OtherAccruedLiabilitiesCurrentAndNoncurrent Other Accrued Liabilities USD 4.06M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap OtherAdditionalCapital Other Additional Capital USD 3.83M 2024-08-12 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap OtherAssets Other Assets USD 68.78M 2023-12-31 2024 Q1 10-Q 2024-02-14 0001213900-24-014096
us-gaap OtherAssetsCurrent Other Assets, Current USD 19.40M 2017-06-30 2017 Q3 10-Q 2017-08-14 0001477932-17-003946
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 98.17M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap OtherBorrowings Other Borrowings USD 1.00M 2025-06-02 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap OtherCommitment Other Commitment USD 18.30M 2025-06-30 2025 Q3 10-Q 2025-08-12 0001213900-25-074997
us-gaap OtherCommitmentDueInNextTwelveMonths Other Commitment, to be Paid, Year One USD 5.40M 2025-06-30 2025 Q3 10-Q 2025-08-12 0001213900-25-074997
us-gaap OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear Other Commitment, to be Paid, Remainder of Fiscal Year USD 11.90M 2025-06-30 2025 Q3 10-Q 2025-08-12 0001213900-25-074997
us-gaap OtherExpenses Other Expenses USD 1.80M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap OtherIncome Other Income USD 59,917 2020-10-01 2021-09-30 2022 FY 10-K 2022-12-22 0001213900-22-082217
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 48,000 2015-10-01 2016-09-30 2016 FY 10-K 2016-12-23 0001477932-16-014315
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 3.59M 2022-10-01 2023-09-30 2023 FY 10-K 2023-12-29 0001213900-23-099889
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 460,000 2015-10-01 2016-09-30 2016 FY 10-K 2016-12-23 0001477932-16-014315
us-gaap OtherOperatingIncome Other Operating Income USD 818,343 2017-10-01 2018-09-30 2019 FY 10-K 2019-12-16 0001213900-19-026259
us-gaap OtherOperatingIncomeExpenseNet Other Operating Income (Expense), Net USD 4.44M 2022-10-01 2023-06-30 2023 Q3 10-Q 2023-08-14 0001213900-23-067024
us-gaap OtherOwnershipInterestsOfferingCosts Other Ownership Interests, Offering Costs USD 15,950 2023-06-30 2023 Q3 10-Q 2023-08-14 0001213900-23-067024
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 64,210 2025-09-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 818,343 2018-09-30 2019 FY 10-K 2019-12-16 0001213900-19-026259
us-gaap OtherResearchAndDevelopmentExpense Other Research and Development Expense USD 19.40M 2022-10-01 2023-09-30 2023 FY 10-K 2023-12-29 0001213900-23-099889
us-gaap PartnersCapitalAccountOptionExercise Partners' Capital Account, Option Exercise USD 100,000 2020-04-01 2020-04-30 2021 FY 10-K 2021-12-15 0001213900-21-065464
us-gaap PartnersCapitalAccountPublicSaleOfUnitsNetOfOfferingCosts Partners' Capital Account, Public Sale of Units Net of Offering Costs USD 760,459 2017-10-01 2018-06-30 2018 Q3 10-Q 2018-08-14 0001213900-18-011072
us-gaap PaymentsForAdvanceToAffiliate Payments for Advance to Affiliate USD 1.33M 2024-10-01 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap PaymentsForDeposits Payments for Deposits USD 54,926 2018-10-01 2019-09-30 2020 FY 10-K 2020-12-16 0001213900-20-043004
us-gaap PaymentsForFees Payments for Other Fees USD 20.10M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap PaymentsForLeasingCosts Payments for Leasing Costs USD 1.10M 2023-10-01 2024-03-31 2024 Q2 10-Q 2024-05-14 0001213900-24-042920
us-gaap PaymentsForRepurchaseOfPreferredStockAndPreferenceStock Payments for Repurchase of Preferred Stock and Preference Stock USD 100 2024-10-01 2025-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 64,801 2015-10-01 2016-09-30 2018 FY 10-K 2018-12-11 0001213900-18-017214
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 892,551 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap PaymentsOfLoanCosts Payments of Loan Costs USD 2.35M 2025-07-15 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap PaymentsOfMergerRelatedCostsFinancingActivities Payments of Merger Related Costs, Financing Activities USD 3.83M 2023-10-01 2024-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 2.36M 2023-10-01 2024-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap PaymentsToAcquireAndDevelopRealEstate Payments to Acquire and Develop Real Estate USD 2,024 2012-01-01 2012-12-31 2014 FY 10-KT 2014-12-29 0001477932-14-007353
us-gaap PaymentsToAcquireInProcessResearchAndDevelopment Payments to Acquire in Process Research and Development USD 40.00M 2020-10-01 2021-09-30 2021 FY 10-K 2021-12-15 0001213900-21-065464
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 5.00M 2025-10-01 2026-03-31 2026 Q2 10-Q 2026-05-15 0001213900-26-057842
us-gaap PaymentsToAcquireOtherProductiveAssets Payments to Acquire Other Productive Assets USD 40.00M 2020-10-01 2021-09-30 2022 FY 10-K 2022-12-22 0001213900-22-082217
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 6,938 2020-10-01 2021-09-30 2022 FY 10-K 2022-12-22 0001213900-22-082217
us-gaap PreferredStockDividendsIncomeStatementImpact Preferred Stock Dividends, Income Statement Impact USD 1.45M 2020-10-01 2021-09-30 2021 FY 10-K 2021-12-15 0001213900-21-065464
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2017-06-30 2017 Q3 10-Q 2017-08-14 0001477932-17-003946
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2017-06-30 2017 Q3 10-Q 2017-08-14 0001477932-17-003946
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2014-06-30 2014 Q3 10-Q 2014-08-14 0001185185-14-002170
us-gaap PrepaidAdvertising Prepaid Advertising USD 300,000 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 3.01M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap PrepaidExpenseCurrentAndNoncurrent Prepaid Expense USD 2.70M 2024-09-30 2025 Q3 10-Q 2025-08-12 0001213900-25-074997
us-gaap PrepaidInsurance Prepaid Insurance USD 180,380 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap ProceedsFromCommissionsReceived Proceeds from Commissions Received USD 6.29M 2018-10-01 2019-09-30 2019 FY 10-K 2019-12-16 0001213900-19-026259
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 225,000 2013-01-01 2013-12-31 2014 FY 10-KT 2014-12-29 0001477932-14-007353
us-gaap ProceedsFromDebtNetOfIssuanceCosts Proceeds from Debt, Net of Issuance Costs USD 1.77M 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 6.04M 2024-10-01 2025-03-31 2025 Q2 10-Q 2025-05-14 0001213900-25-043360
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 25.27M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 10.00M 2015-10-01 2016-09-30 2016 FY 10-K 2016-12-23 0001477932-16-014315
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 100 2024-10-01 2025-06-30 2025 Q3 10-Q 2025-08-12 0001213900-25-074997
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 125,000 2025-09-10 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap ProceedsFromIssuanceOfSecuredDebt Proceeds from Issuance of Secured Debt USD 600,000 2013-01-01 2013-12-31 2015 FY 10-K 2015-12-14 0001477932-15-007617
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised USD 70.98M 2020-10-01 2021-09-30 2022 FY 10-K 2022-12-22 0001213900-22-082217
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 9.00M 2025-09-10 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 1.00M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap ProceedsFromLinesOfCredit Proceeds from Lines of Credit USD 9.63M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 1.30M 2024-10-01 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap ProceedsFromOtherEquity Proceeds from Other Equity USD 657,284 2025-07-01 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 164,583 2019-10-01 2020-09-30 2021 FY 10-K 2021-12-15 0001213900-21-065464
us-gaap ProceedsFromRepaymentsOfBankOverdrafts Proceeds from (Repayments of) Bank Overdrafts USD -9 2013-10-01 2014-06-30 2014 Q3 10-Q 2014-08-14 0001185185-14-002170
us-gaap ProceedsFromRepaymentsOfNotesPayable Proceeds from (Repayments of) Notes Payable USD -1.00M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap ProceedsFromRepaymentsOfRelatedPartyDebt Proceeds from (Repayments of) Related Party Debt USD -600,000 2015-10-01 2016-09-30 2018 FY 10-K 2018-12-11 0001213900-18-017214
us-gaap ProceedsFromRoyaltiesReceived Proceeds from Royalties Received USD 1.10M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 31,267 2022-10-01 2023-09-30 2024 FY 10-K 2024-12-27 0001213900-24-113149
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 3.65M 2023-10-01 2024-06-30 2024 Q3 10-Q 2024-08-12 0001213900-24-067732
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 9.73M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap ProductionAndDistributionCosts Production and Distribution Costs USD 17.30M 2024-10-01 2024-12-31 2025 Q1 10-Q 2025-02-14 0001213900-25-014321
us-gaap ProfessionalFees Professional Fees USD 84,735 2023-10-01 2024-09-30 2024 FY 10-K 2024-12-27 0001213900-24-113149
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -49.42M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 10,648 2017-09-30 2017 FY 10-K 2017-12-13 0001213900-17-013191
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 1,432 2023-09-30 2024 FY 10-K 2024-12-27 0001213900-24-113149
us-gaap PurchaseObligation Purchase Obligation USD 16.20M 2025-12-31 2026 Q1 10-Q 2026-02-13 0001213900-26-015878
us-gaap PurchaseObligationDueInNextTwelveMonths Purchase Obligation, to be Paid, Year One USD 6.30M 2025-12-31 2026 Q1 10-Q 2026-02-13 0001213900-26-015878
us-gaap PurchaseObligationDueInSecondYear Purchase Obligation, to be Paid, Year Two USD 9.90M 2025-12-31 2026 Q1 10-Q 2026-02-13 0001213900-26-015878
us-gaap PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear Purchase Obligation, to be Paid, Remainder of Fiscal Year USD 2.90M 2025-06-30 2025 Q3 10-Q 2025-08-12 0001213900-25-074997
us-gaap ReimbursementFromLimitedPartnershipInvestment Reimbursement from Limited Partnership Investment USD 292,575 2016-01-01 2016-03-31 2016 FY 10-K 2016-12-23 0001477932-16-014315
us-gaap ReimbursementRevenue Reimbursement Revenue (Deprecated 2018-01-31) USD 292,575 2016-01-01 2016-03-31 2017 FY 10-K 2017-12-13 0001213900-17-013191
us-gaap RelatedPartyTransactionDueFromToRelatedParty Related Party Transaction, Due from (to) Related Party USD 27,637 2016-09-30 2016 FY 10-K 2016-12-23 0001477932-16-014315
us-gaap RepaymentOfNotesReceivableFromRelatedParties Repayment of Notes Receivable from Related Parties USD -600,000 2015-10-01 2016-06-30 2017 Q3 10-Q 2017-08-14 0001477932-17-003946
us-gaap RepaymentsOfDebt Repayments of Debt USD 30,147 2010-09-09 2014-03-31 2014 Q2 10-Q 2014-05-15 0001185185-14-001283
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 1.00M 2025-10-01 2026-03-31 2026 Q2 10-Q 2026-05-15 0001213900-26-057842
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 300,000 2024-10-01 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 4.29M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost Research and Development Expense (Excluding Acquired in Process Cost) USD 100,000 2020-04-01 2020-04-30 2022 FY 10-K 2022-12-22 0001213900-22-082217
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 741,843 2018-10-01 2019-09-30 2019 FY 10-K 2019-12-16 0001213900-19-026259
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -277.12M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 90,000 2021-10-01 2022-09-30 2022 FY 10-K 2022-12-22 0001213900-22-082217
us-gaap RevenueRemainingPerformanceObligationPercentage Revenue, Remaining Performance Obligation, Percentage pure 0.02 2025-07-15 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap Revenues Revenues USD 7.11M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 786,697 2024-10-01 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap RoyaltyExpense Royalty Expense USD 100,000 2023-10-01 2024-03-31 2024 Q2 10-Q 2024-05-14 0001213900-24-042920
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 626,843 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap SaleOfStockConsiderationReceivedPerTransaction Sale of Stock, Consideration Received Per Transaction USD 657,284 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 4.73M 2026-04-24 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 0.985 2026-04-24 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap SettlementLiabilitiesCurrent Settlement Liabilities, Current USD 1.06M 2026-05-05 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 11.88M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price USD/shares 9.75 2017-06-07 2017 Q3 10-Q 2017-08-14 0001477932-17-003946
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2022-10-01 2023-09-30 2023 FY 10-K 2023-12-29 0001213900-23-099889
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 1.16 2017-10-01 2018-09-30 2018 FY 10-K 2018-12-11 0001213900-18-017214
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.018 2014-01-01 2014-09-30 2015 FY 10-K 2015-12-14 0001477932-15-007617
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate pure 0 2016-10-01 2017-09-30 2017 FY 10-K 2017-12-13 0001213900-17-013191
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted shares 11.73M 2022-10-01 2023-09-30 2023 FY 10-K 2023-12-29 0001213900-23-099889
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Other shares 2.00M 2017-10-01 2018-06-30 2018 Q3 10-Q 2018-08-14 0001213900-18-011072
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number shares 350,000 2026-03-24 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 7.58M 2024-06-30 2024 Q3 10-Q 2024-08-12 0001213900-24-067732
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 0 2024-12-31 2025 Q1 10-Q 2025-02-14 0001213900-25-014321
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 502,184 2024-12-31 2025 Q1 10-Q 2025-02-14 0001213900-25-014321
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 40.62 2024-12-31 2025 Q1 10-Q 2025-02-14 0001213900-25-014321
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 39,068 2023-10-01 2024-09-30 2024 FY 10-K 2024-12-27 0001213900-24-113149
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 40,398 2023-10-01 2024-09-30 2024 FY 10-K 2024-12-27 0001213900-24-113149
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 5.52 2022-10-01 2023-06-30 2023 Q3 10-Q 2023-08-14 0001213900-23-067024
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 88,500 2022-10-01 2023-06-30 2023 Q3 10-Q 2023-08-14 0001213900-23-067024
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 185,000 2024-10-01 2024-12-31 2025 Q1 10-Q 2025-02-14 0001213900-25-014321
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 7.15 2024-10-01 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 203,000 2026-03-24 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 841,084 2024-12-31 2025 Q1 10-Q 2025-02-14 0001213900-25-014321
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Period Increase (Decrease) shares 13.31M 2022-10-01 2023-09-30 2023 FY 10-K 2023-12-29 0001213900-23-099889
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 30.49 2024-12-31 2025 Q1 10-Q 2025-02-14 0001213900-25-014321
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 56,203 2023-09-30 2023 FY 10-K 2023-12-29 0001213900-23-099889
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value USD/shares 13.38 2023-10-01 2024-09-30 2024 FY 10-K 2024-12-27 0001213900-24-113149
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period shares 445,932 2017-01-01 2017-01-31 2017 Q2 10-Q 2017-05-15 0001477932-17-002308
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0.38 2023-10-01 2024-09-30 2024 FY 10-K 2024-12-27 0001213900-24-113149
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 68.5 2023-10-01 2024-09-30 2024 FY 10-K 2024-12-27 0001213900-24-113149
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 9.5 2024-10-01 2024-12-31 2025 Q1 10-Q 2025-02-14 0001213900-25-014321
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Other Share Increase (Decrease) in Period, Weighted Average Exercise Price USD/shares 0.53 2023-10-01 2024-06-30 2024 Q3 10-Q 2024-08-12 0001213900-24-067732
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit USD/shares 1.5 2023-05-08 2023 Q3 10-Q 2023-08-14 0001213900-23-067024
us-gaap ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Dividend Rate pure 0 2019-10-01 2020-09-30 2020 FY 10-K 2020-12-16 0001213900-20-043004
us-gaap SharePrice Share Price USD/shares 1.09 2025-07-17 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap SharesIssued Shares, Issued shares 1.51M 2023-06-30 2023 Q3 10-Q 2023-08-14 0001213900-23-067024
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 0.58 2026-03-24 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap SharesSubjectToMandatoryRedemptionSettlementTermsMaximumNumberOfShares Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Maximum Number of Shares shares 12.04M 2022-12-31 2023 Q1 10-Q 2023-02-10 0001213900-23-010315
us-gaap ShortTermDebtPercentageBearingFixedInterestRate Short-term Debt, Percentage Bearing Fixed Interest Rate pure 0.12 2017-12-31 2018 Q1 10-Q 2018-02-14 0001213900-18-001880
us-gaap ShortTermDebtWeightedAverageInterestRate Short-term Debt, Weighted Average Interest Rate, at Point in Time pure 0.15 2025-06-02 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants USD 297 2025-04-01 2025-06-30 2025 Q3 10-Q 2025-08-12 0001213900-25-074997
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 66.61M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 75.91M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap StockholdersEquityOther Stockholders' Equity, Other USD 500 2020-10-01 2021-09-30 2021 FY 10-K 2021-12-15 0001213900-21-065464
us-gaap StockIssued1 Stock Issued USD 98,079 2024-01-17 2024 Q2 10-Q 2024-05-14 0001213900-24-042920
us-gaap StockIssuedDuringPeriodSharesConversionOfUnits Stock Issued During Period, Shares, Conversion of Units shares 100,000 2023-03-01 2023-03-27 2023 Q3 10-Q 2023-08-14 0001213900-23-067024
us-gaap StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans Stock Issued During Period, Shares, Employee Stock Purchase Plans shares 75,000 2023-04-10 2023 Q3 10-Q 2023-08-14 0001213900-23-067024
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 128,205 2024-01-17 2024 Q2 10-Q 2024-05-14 0001213900-24-042920
us-gaap StockIssuedDuringPeriodSharesOther Stock Issued During Period, Shares, Other shares 442,715 2025-07-01 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap StockIssuedDuringPeriodSharesPurchaseOfAssets Stock Issued During Period, Shares, Purchase of Assets shares 12.55M 2023-07-05 2023 Q3 10-Q 2023-08-14 0001213900-23-067024
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 2,125 2023-10-01 2024-09-30 2024 FY 10-K 2024-12-27 0001213900-24-113149
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 19.02M 2015-10-01 2016-09-30 2018 FY 10-K 2018-12-11 0001213900-18-017214
us-gaap StockIssuedDuringPeriodValueConversionOfUnits Stock Issued During Period, Value, Conversion of Units USD 178,000 2022-03-01 2022-03-21 2022 Q3 10-Q 2022-08-11 0001213900-22-046897
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 107,510 2025-10-01 2025-12-31 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 349,254 2025-10-01 2025-12-31 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 2.57M 2024-10-01 2024-12-31 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 3.81M 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap StockIssuedDuringPeriodValueStockDividend Stock Issued During Period, Value, Stock Dividend USD 102,000 2023-03-01 2023-03-27 2023 Q3 10-Q 2023-08-14 0001213900-23-067024
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 34 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap StockRedeemedOrCalledDuringPeriodValue Stock Redeemed or Called During Period, Value USD 100 2025-04-01 2025-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased shares 35,000 2022-12-31 2023 Q1 10-Q 2023-02-10 0001213900-23-010315
us-gaap TreasuryStockCommonShares Treasury Stock, Common, Shares shares 500,000 2020-07-13 2022 FY 10-K 2022-12-22 0001213900-22-082217
us-gaap UnrealizedGainLossOnDerivatives Unrealized Gain (Loss) on Derivatives USD -308,878 2016-10-01 2017-06-30 2017 Q3 10-Q 2017-08-14 0001477932-17-003946
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 79,433 2023-06-30 2023 Q3 10-Q 2023-08-14 0001213900-23-067024
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 12.32M 2024-10-01 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap ValuationAllowancesAndReservesPeriodIncreaseDecrease SEC Schedule, 12-09, Valuation Allowances and Reserves, Period Increase (Decrease) USD 1.30M 2014-10-01 2015-09-30 2015 FY 10-K 2015-12-14 0001477932-15-007617
us-gaap VariableLeaseCost Variable Lease, Cost USD 398 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap WarrantExercisePriceIncrease Warrant, Exercise Price, Increase USD/shares 18.75 2024-04-30 2025 FY 10-K 2025-12-23 0001213900-25-125333
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 13.20M 2025-12-10 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 23.34M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 146.01M 2021-10-01 2021-12-31 2022 Q1 10-Q 2022-02-10 0001213900-22-006429
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 23.34M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090185
us-gaap WriteOffOfDeferredDebtIssuanceCost Write off of Deferred Debt Issuance Cost USD 5,401 2015-10-01 2016-06-30 2017 Q3 10-Q 2017-08-14 0001477932-17-003946

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →